Publications by authors named "Celine Callens"

Claim this Profile
T
Therapeutic advances and molecular insights in low-grade serous ovarian carcinoma.
Rayan Kabirian, Thomas Gaillard, Diana Bello-Roufai, Caroline Malhaire, Virginie Huchet, Céline Callens

Bull Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?: Lessons From the PAOLA-1/ENGOT-ov25 Trial, a GINECO Study.
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, Céline Callens, Frédéric Selle

Arch Pathol Lab Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.
Florence Joly, Alexandra Leary, Isabelle Ray-Coquard, Bernard Asselain, Manuel Rodrigues, Céline Callens

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.
Max Piffoux, Alexandra Leary, Philippe Follana, Cyril Abdeddaim, Florence Joly, Celine Callens

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy.
François Bertucci, Arnaud Guille, Florence Lerebours, Michele Ceccarelli, Najeeb Syed, Céline Callens

J Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas.
Lounes Djerroudi, Ahmad El Sabeh-Ayoun, Camille Benoist, Gaelle Pierron, Julien Masliah-Planchon, Celine Callens

Mod Pathol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis.
Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, Céline Callens

Oncogene· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational landscape of inflammatory breast cancer.
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Céline Callens

J Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
Célia Dupain, Tom Gutman, Elodie Girard, Choumouss Kamoun, Grégoire Marret, Céline Callens

BMC Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial.
Celine Callens, Manuel Rodrigues, Adrien Briaux, Eleonore Frouin, Alexandre Eeckhoutte

Oncogene· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.
Mathias Schwartz, Virginie Moncoutier, Adrien Peytral, Jessica Le Gall, Voreak Suybeng, Céline Callens

Clin Genet· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients.
Julien Corné, Véronique Quillien, Céline Callens, Pascal Portois, François-Clément Bidard

Clin Chim Acta· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer.
Clémence Basse, Olfa Trabelsi-Grati, Julien Masliah, Céline Callens, Maud Kamal

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report.
Olfa Trabelsi Grati, Leila Zemoura, Caroline Nhy, Catherine Daniel, Samia Melaabi, Céline Callens

Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
François-Clément Bidard, Anne-Claire Hardy-Bessard, Florence Dalenc, Thomas Bachelot, Jean-Yves Pierga, Céline Callens

Lancet Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Celine Callens, Francois-Clement Bidard, Anaïs Curto-Taribo, Olfa Trabelsi-Grati, Samia Melaabi

Anal Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation.
Anne Patsouris, Kadija Diop, Olivier Tredan, Daniel Nenciu, Anthony Gonçalves, Céline Callens

Eur J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis.
Molly M Wilson, Céline Callens, Matthieu Le Gallo, Svetlana Mironov, Qiong Ding

Sci Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.
Céline Callens, Dominique Vaur, Isabelle Soubeyran, Etienne Rouleau, Pierre-Alexandre Just

J Natl Cancer Inst· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Céline Callens, Keltouma Driouch, Anaïs Boulai, Zakia Tariq, Aurélie Comte

Genome Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas.
Didier Meseure, Kinan Drak Alsibai, Sophie Vacher, Rana Hatem, Andre Nicolas, Celine Callens

Anal Cell Pathol (Amst)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial.
Célia Dupain, Julien Masliah-Planchon, Céline Gu, Elodie Girard, Pierre Gestraud, Céline Callens

Mol Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases.
Marie Mayenga, Jean-Baptiste Assié, Isabelle Monnet, Marie-Ange Massiani, Laure Tabeze, Céline Callens

Lung Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Exon 14 Mutation Associated With Resistance to Alectinib in a Patient With Rearranged NSCLC.
Catherine Daniel, Celine Callens, Samia Melaabi, Ivan Bieche, Nicolas Girard

JTO Clin Res Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of cancers: a place for iron chelators?].
Céline Callens

Rev Prat· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis